Literature DB >> 7317271

A comparison of the response to hyperthermia of murine haemopoietic stem cells (CFU-S) and L1210 leukaemia cells: enhanced killing of leukaemic cells in presence of normal marrow cells.

R P Symonds, T E Wheldon, B Clarke, G Bailey.   

Abstract

When the clonogenic survival of mouse haemopoietic stem cells (CFU-S) and leukaemia L1210 cells growth as ascites tumours are compared after being heated in vitro and assayed in vivo by spleen-colony assay, there is no significant difference in the terminal slopes of the survival curves. The shoulders of the survival curves differ, but this may be explained by differences in cell kinetics. By contrast, L1210 leukaemic marrow cells are considerably more susceptible to the lethal effects of hyperthermia (43 degrees C) than either normal marrow stem cells or L1210 leukaemic cells grown as ascites tumours. Moreover, the killing of L1210 ascites cells by hyperthermia can be enhanced by heating L1210 ascites cells with an equal number of normal marrow cells, or as upernatant removed from heated marrow cells. Most cells in lukaemic marrow are normal, and it is postulated that the increased thermal sensitivity of L1210 cells in leukaemic marrow is caused by diffusible factors (e.g. lysosomal enzymes) released by heating normal marrow cells.

Entities:  

Mesh:

Year:  1981        PMID: 7317271      PMCID: PMC2010829          DOI: 10.1038/bjc.1981.254

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  HAEMATOPOIETIC STEM CELLS.

Authors:  J P LEWIS; F E TROBAUGH
Journal:  Nature       Date:  1964-11-07       Impact factor: 49.962

2.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

3.  EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.

Authors:  H E SKIPPER; F M SCHABEL; W S WILCOX
Journal:  Cancer Chemother Rep       Date:  1964-02

4.  Two qualitatively different effects of hyperthermia on acid phosphatase staining in mouse spleen, dependent on the severity of the treatment.

Authors:  S P Hume; M A Rogers; S B Field
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1978-11

Review 5.  Hyperthermia in the treatment of cancer.

Authors:  S B Field; N M Bleehen
Journal:  Cancer Treat Rev       Date:  1979-06       Impact factor: 12.111

6.  Acute promyelocytic leukemia: results of treatment by daunorubicin.

Authors:  J Bernard; M Weil; M Boiron; C Jacquillat; G Flandrin; M F Gemon
Journal:  Blood       Date:  1973-04       Impact factor: 22.113

7.  Temperature-induced variations in the surface topology of cultured lymphocytes are revealed by scanning electron microscopy.

Authors:  P S Lin; D F Wallach; S Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

8.  Analysis of variations in the cell population kinetics with tumor age in the L1210 ascites tumor.

Authors:  P Dombernowsky; N R Hartmann
Journal:  Cancer Res       Date:  1972-11       Impact factor: 12.701

9.  A linear transform of the multi-target survival curve.

Authors:  J V Watson
Journal:  Br J Radiol       Date:  1978-07       Impact factor: 3.039

10.  Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.

Authors:  G M Hahn; J Braun; I Har-Kedar
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  4 in total

1.  Heat shock proteins and Bcl-2 expression and function in relation to the differential hyperthermic sensitivity between leukemic and normal hematopoietic cells.

Authors:  R Setroikromo; P K Wierenga; M A W H van Waarde; J F Brunsting; E Vellenga; H H Kampinga
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

2.  Thermal sensitivity of haemopoietic and stromal progenitor cells in different proliferative states.

Authors:  S B Wang; J H Hendry; N G Testa
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

3.  The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.

Authors:  M J Blackburn; T E Wheldon; S B Field; J M Goldman
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

4.  Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.

Authors:  D J Honess; N M Bleehen
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.